Publications
2008
Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders.
Pietra D,
Li S,
Brisci A,
Passamonti F,
Rumi E,
Theocharides A,
Ferrari M,
Gisslinger H,
Kralovics R,
Cremonesi L,
Skoda R,
Cazzola M.
Blood 2008, 111:1686–1689.
2008
Unique Effects of KIT D816V in BaF3 Cells: Induction of Cluster Formation, Histamine Synthesis, and Early Mast Cell Differentiation Antigens.
Mayerhofer M,
Gleixner KV,
Hoelbl A,
Florian S,
Hoermann G,
Aichberger KJ,
Bilban M,
Esterbauer H,
Krauth MT,
Sperr WR,
Longley JB,
Kralovics R,
Moriggl R,
Zappulla J,
Liblau RS,
Schwarzinger I,
Sexl V,
Sillaber C,
Valent P.
The Journal of Immunology, 2008, 180: 5466–5476.
2008
A de novo splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia in a Polish family.
Liu K,
Kralovics R,
Rudzki Z,
Grabowska B,
Buser AS,
Olcaydu D,
Gisslinger H,
Tiedt R,
Frank P,
Okon K,
Van der Maas APC and Skoda RC.
Haematologica 2008, 93(5); 706–14.
2008
Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations.
Li S,
Kralovics R,
De Libero G,
Theocharides A,
Gisslinger H,
Skoda RC.
Blood 2008, 111: 3863–3866. <link http://bloodjournal.hematologylibrary.org/content/111/7/3863.long>(abstract)</link>
2008
Genetic complexity of myeloproliferative neoplasms.
Kralovics R.
Leukemia. 2008 Oct;22(10):1841–8. Review.
